The Future Biotech Expo is your launchpad to global influence.

Global Market Outlook

The global biotechnology industry is entering a new era defined by precision, personalization, and planetary impact. Valued at $1.37 trillion in 2023, the global biotech market is projected to exceed $3.8 trillion by 2030, driven by breakthroughs in genomics, immunotherapy, bio-manufacturing, and AI-powered drug discovery.

Across continents, governments are prioritizing biotech to solve challenges in public health, food security, climate resilience, and sustainability. Startups, academic institutions, and Fortune 500 firms alike are investing in platforms that are revolutionizing healthcare, agriculture, and the environment.

Global Trends Driving Growth

• Explosive demand for mRNA, CRISPR & cell-based therapies

• AI and big data transforming R&D and diagnostics

• Rise of bioeconomies and public-private innovation clusters

• Climate-focused biotech in agriculture, materials, and energy

• Cross-border R&D, licensing, and M&A deals expanding rapidly

Whether you're based in Asia, Europe, or LATAM, the biotechnology world is more interconnected and competitive than ever before. Global collaboration is no longer optional — it’s a necessity.

Local Market Outlook — United States

As the world’s biotech superpower, the United States commands over 50% of global biotech investment. Home to 10 of the top 15 biotech clusters and fueled by institutions like NIH, Stanford, and MIT, the U.S. is unmatched in its ability to commercialize life-changing science.

With a robust startup pipeline, $200B+ in active venture capital, and an ecosystem spanning healthcare, agri-biotech, bioinformatics, and industrial bio, the U.S. market offers fertile ground for breakthrough discoveries and global expansion.